An enzyme biologic with dual-acting DNASE1/DNASE1L3 activity prevents autoimmunity and death in lupus models, with implications for other diseases characterized by aberrant DNA accumulation. The gene discussed is DNASE1; the disease is systemic lupus erythematosus.